A detailed history of Eagle Claw Capital Managment, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 7,074 shares of BDX stock, worth $1.62 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
7,074
Previous 7,074 -0.0%
Holding current value
$1.62 Million
Previous $1.72 Million 1.51%
% of portfolio
0.33%
Previous 0.37%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$254.9 - $283.59 $61,176 - $68,061
240 Added 3.51%
7,074 $1.83 Million
Q4 2022

Feb 09, 2023

BUY
$218.29 - $256.91 $43,658 - $51,382
200 Added 3.01%
6,834 $1.74 Million
Q4 2022

Feb 06, 2023

SELL
$218.29 - $256.91 $43,658 - $51,382
-200 Reduced 2.93%
6,634 $1.69 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $103,536 - $112,923
450 Added 7.05%
6,834 $1.72 Million
Q2 2021

Aug 10, 2021

BUY
$232.65 - $254.58 $224,972 - $246,178
967 Added 17.85%
6,384 $1.55 Million
Q1 2021

May 12, 2021

SELL
$232.09 - $256.88 $4,641 - $5,137
-20 Reduced 0.37%
5,417 $1.32 Million
Q3 2020

Nov 09, 2020

BUY
$215.77 - $276.76 $172,616 - $221,408
800 Added 17.25%
5,437 $1.27 Million
Q3 2019

Oct 22, 2019

SELL
$230.58 - $256.08 $46,116 - $51,216
-200 Reduced 4.13%
4,637 $1.17 Million
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $11,653 - $12,800
50 Added 1.04%
4,837 $1.26 Million
Q1 2018

May 18, 2018

SELL
$205.46 - $240.27 $43,762 - $51,177
-213 Reduced 4.26%
4,787 $1.04 Million
Q4 2017

Feb 13, 2018

BUY
$189.0 - $222.64 $42,336 - $49,871
224 Added 4.69%
5,000 $1.07 Million
Q3 2017

Nov 16, 2017

SELL
$186.89 - $198.9 $93,445 - $99,450
-500 Reduced 9.48%
4,776 $937,000
Q2 2017

Aug 15, 2017

BUY
N/A
5,276
5,276 $1.03 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Eagle Claw Capital Managment, LLC Portfolio

Follow Eagle Claw Capital Managment, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Claw Capital Managment, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Claw Capital Managment, LLC with notifications on news.